Statistics

Total Visits

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study55

Select a period of time:

Number of views in the range

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study12

Views

Views
May 20251
June 20250
July 20257
August 20250
September 20253
October 20251
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States2
Ecuador1
United Kingdom1
Mexico1
 

Top cities views

Views
Brasília1
Curitiba1
Guarantã do Norte1
Guayaquil1
Kearny1
Limoeiro do Norte1
São Paulo1
Tijuana1
Torquay1
Torres1